Mount Sinai leads large multicenter study finding evidence that a drug might slow Parkinson's

Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report today in The New England Journal of Medicine that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.

Read the whole article on Science Blog

More from Science Blog